CardioComm Solutions and Predictiv AI Enter into Strategic AI Collaboration

CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a provider of consumer heart monitoring, remote ...

Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...
MobiHealthNews

FDA clears Biofourmis' software for ECG-based arrhythmia detection

The FDA has granted 510(k) clearance to Biofourmis’ RhythmAnalytics, a cloud-based software product that uses deep learning to read and interpret cardiac arrhythmias. According to a statement from the ...
Becker's Hospital Review

ECG software analytics company joins Innovators’ Network at American Heart Association

Electrocardiogram software analytics company AccurKardia is joining the Innovators’ Network at the American Heart Association Center for Health and Technology Innovation. The Innovator’s Network is a ...

HeartBeam (NASDAQ: BEAT) Study Shows Portable ECG Device Can Help Identify Heart Attack Risk

HeartBeam (NASDAQ: BEAT) a medical technology company focused on transforming cardiac care by providing powerful ...
Business Wire

Cardiac Insight Awarded Wearable Medical Devices and Mobile Medical Applications Category Group Purchasing Agreement with Premier

BELLEVUE, Wash.--(BUSINESS WIRE)--Cardiac Insight, Inc. (“Cardiac Insight” or the “Company) is a healthcare innovator specializing in wearable cardiac sensors and proprietary software that ...
Investing

HeartBeam’s ECG software shows promise in clinical study

SANTA CLARA, Calif. – HeartBeam, Inc. (NASDAQ: BEAT), a pioneer in cardiac care technology with a market capitalization of $65.76 million, has announced positive results from its VALID-ECG pivotal ...
Daily Express

Fears Apple Watch ECG could flood NHS with hypochondriacs – 'likely cause huge anxiety'

Apple’s latest smartwatch can now detect signs of a deadly heart condition – potentially saving lives across the UK. But Dr Helen Tyrer, a senior clinical research fellow at Imperial College London, ...